Kavanaugh, A., van Vollenhoven, R. F., Fleischmann, R., Emery, P., Sainsbury, I., Florentinus, S., . . . Smolen, J. S. (2018). Testing treat-to-target outcomes with initial methotrexate monotherapy compared with initial tumour necrosis factor inhibitor (adalimumab) plus methotrexate in early rheumatoid arthritis. Ann Rheum Dis.
استشهاد بنمط شيكاغوKavanaugh, Arthur, et al. "Testing Treat-to-target Outcomes With Initial Methotrexate Monotherapy Compared With Initial Tumour Necrosis Factor Inhibitor (adalimumab) Plus Methotrexate in Early Rheumatoid Arthritis." Ann Rheum Dis 2018.
MLA استشهادKavanaugh, Arthur, et al. "Testing Treat-to-target Outcomes With Initial Methotrexate Monotherapy Compared With Initial Tumour Necrosis Factor Inhibitor (adalimumab) Plus Methotrexate in Early Rheumatoid Arthritis." Ann Rheum Dis 2018.